share_log

Canaccord Genuity Maintains Buy on Guardant Health, Lowers Price Target to $30

Canaccord Genuity Maintains Buy on Guardant Health, Lowers Price Target to $30

Canaccord Genuity维持对Guardant Health的买入,将目标价下调至30美元
Benzinga ·  04/29 10:37

Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:GH) with a Buy and lowers the price target from $45 to $30.

Canaccord Genuity分析师凯尔·米克森维持Guardant Health(纳斯达克股票代码:GH)的买入并将目标股价从45美元下调至30美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发